QUE Oncology

QUE Oncology is a company based in Atlanta, Georgia, developing non-hormonal therapies for moderate to severe vasomotor symptoms in postmenopausal women and cancer patients undergoing hormone therapy. Their leading drug candidate, Q-122, aims to provide a non-hormonal treatment for hot flashes in women with breast cancer receiving anti-estrogen therapy. The company was founded through a collaboration between Emory University and the University of Queensland's research commercialization company, UniQuest.

• Healthtech